جست‌وجوی استاد و پژوهشگر

• Clinical neurophysiology
• Chemotherapy-induced peripheral neuropathy
• Axonal degeneration
• +۸ مورد دیگر

Associate Professor Susanna Park is an academic in Neuroscience at the School of Medical Sciences, University of Sydney. She leads a research group investigating neuropathy and neuromuscular diseases, with a focus on chemotherapy-induced peripheral neurotoxicity. Her work emphasizes clinical assessment tools and axonal degeneration mechanisms. Park holds affiliations with the Brain and Mind Centre and the Faculty of Medicine and Health. Education: PhD from University of New South Wales (UNSW) Notable Fellowships: RG Menzies/NHMRC Overseas Biomedical Fellowship (2011–2014) Research Interests: Clinical neurophysiology, blood-based biomarkers, and motor neuron disorders. Her studies address nerve excitability, chemotherapy-induced neuropathy, and inflammatory neuropathies. Park’s translational work includes developing clinical tools for neuropathy assessment in cancer patients. Publications focus on chemotherapy-induced neuropathy mechanisms, axonal degeneration, and biomarker discovery. Recent work explores electroacupuncture for neuropathy management and plasma lipidomics in risk assessment. Awards: 2022 SUPRA Supervisor of the Year finalist, 2018 RD Wright Fellowship Labs/Teams: Brain and Mind Centre, collaborating with international consortia like the Toxic Neuropathy Consortium.

Helen Suhمشاهده پروفایل

استاد

• Environmental Health
• Environmental Epidemiology
• Air Pollution
• +۲ مورد دیگر

Helen Suh is a Professor at Tufts University, jointly appointed in the departments of Civil and Environmental Engineering and Community Health . As an internationally-recognized expert in air pollution health effects, she combines environmental epidemiology , exposure science , and data analytics to investigate how pollutants impact human health. Sc.D. , Harvard University (1993) M.S. , Harvard University (1990) S.B. , Massachusetts Institute of Technology (1985) Her research focuses on three areas: air pollutant impacts on cognitive performance and child development , multi-pollutant health effects , and GIS-based spatio-temporal modeling for epidemiological studies. Recent publications highlight her work on PM2.5 measurement error correction , hormonal disruptions in pregnancy , and machine learning applications in environmental health analysis. Current trends include: Advanced statistical methods for exposure assessment Multi-omics approaches to cardiometabolic health International comparative studies (e.g., Tehran, Puerto Rico) Long-term mortality analysis in Medicare populations Pollution-immune system interactions in vulnerable groups Policy-relevant modeling for air quality standards Helen Suh has served as an Associate Editor for the Journal of Exposure Science and Environmental Epidemiology and advised major U.S. and international health organizations. Her work spans over 150 publications and integrates multidisciplinary team leadership in environmental health science. Her laboratory develops large-scale data analytics tools and spatio-temporal exposure models to support population-level health research. Current projects include air pollution and aging cohorts , urban environmental noise measurement , and epigenetic responses to pollutants .

• Neonatology
• Immunology
• Pediatric Gastroenterology
• +۳ مورد دیگر

Dr. Oluwabunmi (Bunmi) Olaloye is an Assistant Professor of Pediatrics in the Division of Neonatology at Yale School of Medicine. She holds appointments in Neonatal-Perinatal Medicine and is affiliated with the Janeway Society. Her academic background includes an MD from Rutgers New Jersey Medical School, pediatrics residency at University of Texas Medical Branch, and neonatology fellowship at University of Pittsburgh Medical Center. Dr. Olaloye's research focuses on immune dysfunction underlying neonatal intestinal diseases such as necrotizing enterocolitis (NEC) and spontaneous intestinal perforation (SIP). Using cutting-edge techniques like single-cell RNA sequencing and mass cytometry, her work identifies biomarkers and therapeutic targets to improve outcomes for premature infants. Key research areas include fetal immune system maturation, placental immune interactions, and gestational age-specific inflammatory responses. Her publication record spans 12 peer-reviewed articles between 2019-2025, emphasizing translational immunology and neonatal pathophysiology. Notable contributions include defining immune cell trajectories in preterm infants and developing gating guidelines for high-dimensional cytometry data. Current projects involve constructing immune cell atlases across human lifespans and investigating nutritional interventions for intestinal disorders. Laboratory affiliations include the Laboratory for Surgery, Obstetrics & Gynecology where she explores neonatal mucosal immunity. Her work integrates clinical observations with systems immunology approaches to address critical gaps in understanding prematurity-associated gastrointestinal pathologies.

Vita Goeiمشاهده پروفایل

دانشیار

• Molecular Biology
• Pediatric Gastroenterology
• Liver Disease
• +۳ مورد دیگر

Vita Goei is an Associate Professor at the Medical College of Georgia within Augusta University , specializing in Pediatrics with a focus on Pediatric Gastroenterology . Holding an MD from Albert Einstein College of Medicine (1986) and a BA in Biology from Yeshiva University (1979) , she has practiced pediatric gastroenterology since 1996. Education: MD, Albert Einstein College of Medicine (1986) BA, Yeshiva University (1979) Her research career began in molecular biology with seminal work on the GABA(B) receptor gene and MHC class I transcription . She now seeks clinical studies in pediatric GI, particularly liver disease, Cystic Fibrosis , Inflammatory Bowel Disease , and Eosinophilic Esophagitis . Recent publications span antimicrobial therapy, genetic variants, and diagnostic case studies. Certifications: Basic Life Support (AHA, 2023) Georgia Composite Medical Board (2000) Professional service includes continuous affiliation with the Department of Pediatrics (Gastroenterology) since 2007, previously serving in the same department from 2000-2007.

Ram Samudralaمشاهده پروفایل

استاد

• Bioinformatics
• Computational Biology
• Drug Discovery
• +۱۰ مورد دیگر

Ram Samudrala is a Professor and Chief of the Division of Bioinformatics at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences . His research focuses on multiscale computational biology , integrating protein structure prediction , drug discovery , and translational science to address medical challenges. He leads the development of the CANDO platform for therapeutic drug discovery and co-directs the Informatics Core at the Clinical and Translational Sciences Institute. PhD in Computational Biology (University of Maryland, 1997) BA in Computing Science and Genetics (Ohio Wesleyan University, 1993) Postdoctoral Fellowship in Protein Folding (Stanford University, 1997-2001) His work spans structural biology , genomics , and computational drug design , with applications in dentistry , infectious diseases , and cancer . He has received prestigious awards including the NIH Director's Pioneer Award (2010) and multiple Wiki Science Prizes . Samudrala's group collaborates globally, emphasizing in silico methods followed by in vitro and in vivo validation. Key grants include $1.22M NIH NCATS ASPIRE Reduction-to-Practice Award and $4.5M NIH/NLM BRIGHT Training Grant . 2023 Finalist, Clinical and Translational Sciences Institute Clinical Research Achievement Awards 2016 MacArthur Foundation 100&Change Top 50 2008 Alberta Heritage Foundation Visiting Scientist Award 2005 NSF CAREER Award He directs the BRIGHT Short-Term Training Program and serves on multiple editorial boards and review panels. Samudrala's group maintains a Protinfo web server for structural predictions and the Bioverse framework for systems-level analyses.

Philip R Hollandمشاهده پروفایل

دانشیار

• Neuroscience
• Migraine Research
• Headache Disorders
• +۳ مورد دیگر

Dr. Philip R. Holland is a Reader in Neuroscience at King's College London, affiliated with the Wolfson Sensory, Pain and Regeneration Centre within the School of Neuroscience and the Institute of Psychiatry, Psychology & Neuroscience. His research focuses on understanding migraine mechanisms and developing therapies, with a particular emphasis on neurovascular interactions and pain pathways. He leads a team funded by organizations like the Medical Research Council, Wellcome Trust, and European Research Council. Dr. Holland earned his PhD under Prof. Peter Goadsby at University College London, followed by postdoctoral research at UCSF and the University of Edinburgh. He actively engages in teaching, public awareness, and editorial roles (e.g., Cephalalgia). Key awards include the 2020 Medical Research Foundation Emerging Leaders Prize. His work spans clinical and translational research, aiming to bridge basic science with patient care. Education: PhD in Neuroscience, Postgraduate Certificate in Academic Practice (King's College London). External Roles: External Examiner at UCL, Science Editor of CGRP Forum, Associate Editor of Cephalalgia. Grants/Projects: Investigates trigeminal autonomic cephalalgias, neuroendocrine signaling, and novel therapies like cannabidiol combinations. Labs/Teams: Leads a migraine-focused research group exploring neurobiological and pharmacological interventions.

• Genetics
• Biometry
• Public Health
• +۷ مورد دیگر

Samuli Ripatti is a Professor of Biometry at the Faculty of Medicine, University of Helsinki, and Director of the Institute for Molecular Medicine Finland (FIMM). He chairs the Research Council Finland’s Centre of Excellence in Complex Disease Genetics and the EU H2020-funded Intervene Consortium. His research focuses on genetic variation in the Finnish population, particularly its effects on cardiometabolic diseases and cancers, with a strong emphasis on polygenic risk scores for disease prevention and early detection. His work spans Genetic risk prediction models Lipidomic and metabolomic profiling Gene-environment interactions Translational genomics Recent research highlights include 1099 plasma metabolite-disease causal analysis Genetic determinants of weight loss interventions Cardiovascular risk stratification tools Leukocyte lipid metabolism pathways He actively supervises doctoral programs in Integrative Life Science, Social Sciences, Clinical Research, and Population Health, and collaborates with the Broad Institute of MIT and Harvard.

• Genomic Medicine
• Translational Medicine
• Immunogenetics
• +۴ مورد دیگر

Julian Knight is a Professor of Genomic Medicine at the University of Oxford, with affiliations including the Centre for Human Genetics , Merton College , and leadership roles in the NIHR Oxford Biomedical Research Centre and Central and South NHS Genomic Medicine Service . His work bridges clinical practice and research, focusing on translational genomics. Principal Investigator Deputy Director, Centre for Human Genetics Honorary Consultant Physician Tutor and Fellow, Merton College Director, Medical Sciences Division Graduate School Genomic Medicine Theme Lead, NIHR Oxford BRC Research interests include mechanisms of dysregulated immune responses in sepsis , autoimmune disease , and infection . Key contributions involve RNA signature stratification for sepsis outcomes and HLA allele associations in COVID-19 immunogenicity. Current work explores genetic/epigenetic modulators of innate immunity and causal relationships in multi-omic datasets. Recent publications highlight diverse applications of his group’s work: from pleural infection endotyping (2025) to TLR7 variants in severe COVID-19 (2024), with methodological advancements in single-cell demultiplexing (2024) and pathway analysis (2025). Keywords span genomic medicine , immunology , and multi-omic integration . Knight’s leadership extends to clinical implementation of genomics, education (DPhil/MSc programs), and public engagement. Collaborations span institutions including Imperial College , Wellcome Sanger Institute , and Queen Mary University of London .

• Epigenetic Mechanisms
• Drug Discovery
• Target Discovery
• +۷ مورد دیگر

Professor Udo Oppermann serves as Professor of Molecular Biology and Director of Laboratory Sciences at the Institute of Musculoskeletal Sciences, Botnar Research Centre, University of Oxford. He is also Deputy Director of the Oxford Centre of Translational Myeloma Research and a fellow at St Catherine's College. His educational background includes a Diploma in Human Biology (1990) and PhD in Pharmacology and Toxicology (1994), both earned with distinctions from Philipps University Marburg. Prior academic appointments include Associate Professor at Karolinska Institutet (until 2004) and sabbatical work at Yale University. Research focuses on epigenetic mechanisms in disease through drug and target discovery using systems biology and single-cell approaches . Key disease targets include metabolic disorders, inflammatory conditions, and malignant diseases—particularly multiple myeloma and secondary bone cancers. His group pioneers chemical biology applications in primary tumor microenvironments. Current funding sources include Cancer Research UK, Innovate UK, EPSRC, Royal Society-Newton Fund, Bristol Myers Squibb, Bayer Healthcare, GlaxoSmithKline, Blood Cancer UK, and Leducq Foundation. Notable research trends show increasing emphasis on epigenetic regulation in immune cells (2020-2024), single-cell technologies for myeloma (2022-2024), and translational applications of chromatin modifiers (2016-2019). Recent work integrates metabolomics with epigenetic mechanisms in gynecological and hematological disorders. He supervises doctoral research including Singh K.'s 2024 thesis on sonodynamic therapy mechanisms. Leadership roles encompass directing Oxford's Molecular Laboratory Sciences division and co-leading translational myeloma research initiatives.

Maria Eriksdotterمشاهده پروفایل

استاد

• Alzheimer's Disease
• Geriatrics
• Dementia
• +۶ مورد دیگر

Professor Maria Eriksdotter is a leading academic in geriatrics and dementia research at the Karolinska Institutet , holding the Department of Neurobiology, Care Sciences and Society . She also serves as a Senior Consultant in Themes Inflammation and Ageing at Karolinska University Hospital Huddinge and previously as Dean of KI South (2019–2023). Her work spans translational research, clinical trials, and national registry development, with a focus on Alzheimer's disease, cholinergic therapies, and aging. Her research group pioneered NGF cell therapy for Alzheimer's patients, demonstrating safety and cognitive stabilization in clinical trials. She chairs the SveDem registry , tracking over 100,000 dementia patients to refine diagnostics and care. Studies from SveDem revealed mortality reduction with cholinesterase inhibitors and highlighted pandemic-era diagnostic delays. Recent publications analyze dementia subtypes , comorbidities , and precision medicine in neurodegeneration. Her work intersects neuroimaging , epidemiology , and public health policy , addressing ageism and improving geriatric care systems. Collaborations span Karolinska University Hospital , NSGene Inc , and international institutions.

Kimberly Keil Stietzمشاهده پروفایل

استادیار

• Environmental Toxicology
• Neurotoxicology
• Urology
• +۴ مورد دیگر

Kimberly Keil Stietz is an Assistant Professor in the Department of Comparative Biosciences at the University of Wisconsin-Madison School of Veterinary Medicine. Her research focuses on environmental toxicology, neurotoxicology, and urology, particularly examining how developmental exposure to polychlorinated biphenyls (PCBs) affects urinary function. Education: B.S. in Biology, St. Norbert College (2010) Ph.D. in Comparative Biosciences, University of Wisconsin-Madison (2014) Postdoctoral research in neurotoxicology, University of California-Davis (2015-2019) Stietz's lab investigates the effects of environmental contaminants on the lower urinary tract, emphasizing PCB exposure during development. Using in vitro and in vivo mouse models, the lab studies disruptions in bladder epithelium organization, nerve fiber patterning, inflammation, and peripheral-central nervous system crosstalk. Key projects include analyzing PCB impacts on bladder barrier function, innervation patterns, inflammatory responses, and dorsal root ganglia signaling. Recent publications highlight her work on PCB effects across multiple domains: adult female bladder contractility (2023), prostatic collagen changes (2023), machine learning-aided metabolite analysis (2023, 2022), and developmental PCB exposure links to voiding physiology (2022). Her 2021 studies explored behavioral phenotypes in PCB-exposed mice, dendritic effects, and bladder inflammation, while 2019 work included host-microbe interactions and open-source uroflowmetry tools.

Doron Betelمشاهده پروفایل

استادیار

• Computational Genomics
• Bioinformatics
• Single-cell RNA-seq Analysis
• +۳ مورد دیگر

Doron Betel serves as an Assistant Professor at Weill Cornell Medicine's Graduate School of Medical Sciences, with affiliations in both the Physiology, Biophysics & Systems Biology and Computational Biology programs. He directs the Applied Bioinformatics Core (ABC), a central service group providing specialized computational and analytical support for biomedical research across multiple institutions. Dr. Betel's research focuses on developing computational genomic tools for studying human diseases and cellular development, with emphasis on integrative analyses of genomic and epigenomic data from high-throughput assays. His work addresses specific questions related to disease progression, treatment response, stem cell differentiation, and neurological processes through two closely interacting research groups: the Applied Bioinformatics Core and his independent research lab. The analysis of his recent publications reveals a strong emphasis on single-cell and spatial genomics, cross-species data integration, and machine learning applications in cancer immunology and neurodegenerative disease modeling. His research spans multiple high-impact areas including cancer immunotherapy, stem cell biology, diabetes research, and cardiovascular regeneration, with numerous publications in top journals like Nature, Cell, and Nature Immunology. Through the Applied Bioinformatics Core, Dr. Betel provides extensive analytical support across various genomic platforms including single-cell RNA-seq, spatial transcriptomics, ChIP-seq, ATAC-seq, and variant calling. The Core serves as a vital resource for researchers at Weill Cornell Medicine and the broader Tri-Institutional network, offering specialized analysis, computational pipelines, and training services. Dr. Betel maintains extensive collaborations with leading researchers including Lorenz Studer at MSKCC for stem cell and neurodegenerative disease research, Tuomas Tammela for cancer genomics, and multiple immunology researchers studying T cell function in autoimmunity and cancer. His work bridges computational methodology development with direct biomedical applications across multiple disease areas.

Paul D. Hastingsمشاهده پروفایل

استاد

• Developmental Psychology
• Social Development
• Emotional Development
• +۵ مورد دیگر

Paul D. Hastings is a Professor of Psychology at the University of California, Davis, and former Chair of Psychology and Interim Dean of the School of Education. He directs the Healthy Emotions, Relationships and Development Laboratory (HERD Lab) at the Center for Mind and Brain (CMB) and holds affiliations with the Center for Poverty Research and Institute for Global Nutrition. His educational background includes: Ph.D. in Applied Developmental Psychology, University of Toronto M.A. in Experimental Psychology, University of Toronto B.S. in Faculty of Science, McGill University Post-doctoral training, University of Waterloo Professor Hastings' research examines developmental trajectories of physiological, social, and emotional functioning from childhood to adulthood. He investigates how cultural/socioeconomic conditions (context), family/peer relationships (nurture), and biological systems (nature) interact to shape adaptive outcomes like empathy and social competence, as well as maladaptive outcomes including depression, anxiety, and aggression. His international work spans Bangladesh, Canada, Chile, Ghana, India, Jordan, and multiple U.S. states. Recent publications reveal strong trends in adolescent mental health, physiological regulation (particularly parasympathetic activity), and pandemic impacts. Key themes include suicidal behavior prediction through inflammatory markers, prosocial development linked to physiological regulation, cross-cultural parenting effects, and socioeconomic influences on developmental psychopathology. His scientific recognition includes: Fellow of the Association for Psychological Science UC Davis Distinguished Graduate and Postdoctoral Mentorship Award (2022) Professor Hastings has secured major grants from the National Science Foundation, National Institute of Mental Health, MacArthur Foundation, and Lego Foundation. He actively mentors graduate students and leads collaborative international research projects. His lab conducts fieldwork across diverse cultural contexts to examine how structural inequities impact neurobiological development and mental health outcomes. The HERD Lab, directed by Professor Hastings, integrates psychophysiological methods with developmental science to explore how biological and social systems interact in shaping emotional and relational development across the lifespan.

Elliot L. Dimbergمشاهده پروفایل

استاد بالینی

• Neuromuscular Disorders
• Clinical Neurophysiology
• Peripheral Nerve Disorders
• +۴ مورد دیگر

Dr. Elliot L. Dimberg is a neurologist specializing in neuromuscular disorders at Mayo Clinic Hospital in Jacksonville, Florida. He serves as faculty at Mayo Clinic Alix School of Medicine within the Department of Neurology, holding leadership roles including Vice Chair of the Curriculum Committee and Clerkship Sub Committee. Dr. Dimberg actively contributes to medical education through multiple committees related to student promotions, academic affairs, and residency program evaluation, while maintaining a clinical practice focused on complex neuromuscular conditions. Dr. Dimberg earned his MD from Tulane University in 2001. He completed his Neurology residency and served as Chief Resident at the University of Virginia, followed by fellowships in Clinical Neurophysiology at the University of Virginia (2006) and Neuromuscular Disease at Mayo Clinic Rochester (2008). He maintains board certification in Neurology, Clinical Neurophysiology, and Neuromuscular Medicine through the American Board of Psychiatry and Neurology. His clinical expertise spans neuromuscular junction disorders including myasthenia gravis and Lambert-Eaton Myasthenic Syndrome, peripheral neuropathies, brachial and lumbosacral plexus disorders, polyradiculopathies, motor neuron diseases, and myopathies. Dr. Dimberg integrates clinical evaluation with electrodiagnostic medicine to diagnose and manage these complex conditions. His research focuses on advancing diagnostic methodologies through electromyography techniques, genetic testing, and clinical trial participation for rare neuromuscular disorders. Dr. Dimberg's publication record demonstrates consistent contributions to neuromuscular medicine, with emphasis on diagnostic precision, genetic underpinnings of muscle disorders, and therapeutic innovations. His recent work includes clinical trials for hereditary transthyretin amyloidosis, studies on spinal muscular atrophy treatments, and investigations into immune-mediated necrotizing myopathy, reflecting his commitment to advancing both clinical practice and scientific understanding in his field. Multiple Above and Beyond Awards from Mayo Clinic in Florida (2008-2024) A.B. Baker Teacher Recognition Award from American Academy of Neurology (2013, 2021) Commitment to Education Award from Mayo Clinic Alix School of Medicine (2019) Alpha Omega Alpha Honor Society membership (2000) As an educator, Dr. Dimberg has coordinated the Residency Neuroanatomy Course and Clinical Pathological Correlation Conference for over a decade. He previously chaired the Curriculum Committee for the Adult Neurology Residency Program and currently serves in leadership roles for Mayo Clinic Alix School of Medicine's educational committees. His dedication to teaching has been recognized through numerous awards including the prestigious A.B. Baker Teacher Recognition Award. Professionally, Dr. Dimberg serves as Co-Chair of the American Association of Neuromuscular and Electrodiagnostic Medicine's EDX Lab Accreditation Committee and holds leadership positions in the American Clinical Neurophysiology Society. He contributes to developing certification exams, educational programming, and clinical guidelines for these organizations, maintaining active engagement with the broader neuromuscular medicine community.

Megan Laura McCainمشاهده پروفایل

استاد

• Biomedical Engineering
• Tissue Engineering
• Regenerative Medicine
• +۴ مورد دیگر

Megan Laura McCain is a Professor of Biomedical Engineering at the University of Southern California (USC), with a secondary appointment in the Department of Stem Cell Biology and Regenerative Medicine at the Keck School of Medicine. She leads the McCain Lab, focused on developing microphysiological systems, particularly heart- and muscle-on-a-chip models, to study disease mechanisms and therapeutic responses. McCain holds affiliations with the Biomedical Engineering Society, American Society for Cell Biology, and American Heart Association. Her education includes a B.S. in Biomedical Engineering from Washington University in St. Louis (2006), a Ph.D. in Engineering and Applied Sciences from Harvard University (2012), and postdoctoral research at Harvard’s Wyss Institute. Notable awards include the American Heart Association Pre-doctoral Fellowship and Harvard’s Derek Bok Certificate of Distinction in Teaching. McCain’s research integrates tissue engineering, stem cell biology, and microfluidics to model complex biological systems. Her work emphasizes understanding how microenvironments influence cellular behavior in diseases like cardiovascular disorders and muscular dystrophy. Recent studies explore paracrine interactions in engineered tissues, sex-based proteomic differences in vascular cells, and hypoxia-induced signaling in cardiac fibroblasts. Her scientific contributions include advancements in 3D bioprinting, microfluidic platforms for disease modeling, and synthetic biology tools for cellular control. McCain’s lab collaborates widely to translate findings into clinical applications, such as personalized medicine and regenerative therapies.